Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Operating Cash Flow per Share : ¥0.33 (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Operating Cash Flow per Share?

Luoxin Pharmaceuticals Group Stock Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥-0.08. Luoxin Pharmaceuticals Group Stock Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.33.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Luoxin Pharmaceuticals Group Stock Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.40% per year. The lowest was -23.40% per year. And the median was 8.85% per year.

SZSE:002793's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Luoxin Pharmaceuticals Group Stock Co Operating Cash Flow per Share Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Operating Cash Flow per Share Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.11

-0.02

0.08

-0.66

0.43

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.02	0.11	0.16	0.14	-0.08

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Luoxin Pharmaceuticals Group Stock Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's Price-to-Operating-Cash-Flow falls into.

Luoxin Pharmaceuticals Group Stock Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	466.888	/	1083.833
	=	0.43

Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-96.08	/	1222.054
	=	-0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.33

Luoxin Pharmaceuticals Group Stock Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.luoxin.cn

Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.

Executives

Ye Bang Mi	Supervisors
Fang Xiu Bao	Directors, executives
Zhu Fu Lin	Directors, executives
Chen Li	Supervisors
Yao Liang	Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines